Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casodex and Zoladex in Localised Prostate Carcinoma
NCT00293696Phase 4Completed
- Sponsor
- Tampere University
- Start
- Oct 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bicalutamide, goserelin in prostate cancer (PCa), sponsored by Tampere University. Started Oct 2004; status: completed.
02
Drugs
bicalutamidegoserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00293696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293696.